SNAI1 and breast carcinoma: Phenformin also dose-dependently upregulated mRNA levels of CDH1 with concomitant downregulation of VIM, SNAI1, and SNAI2, indicating that phenformin hinders EMT at the transcriptional level in breast cancer cells (Figure 4C).